Formula Growth’s Lantheus LNTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.79M Buy
25,131
+9,131
+57% +$851K 0.98% 35
2026
Q1
$1.21M Buy
+16,000
New +$1.15M 0.55% 73
2025
Q3
Sell
-26,069
Closed -$2.13M 131
2025
Q2
$2.13M Buy
+26,069
New +$2.29M 0.81% 52
2024
Q1
Sell
-45,100
Closed -$2.8M 130
2023
Q4
$2.8M Sell
45,100
-4,100
-8% -$278K 0.9% 44
2023
Q3
$3.42M Buy
49,200
+16,711
+51% +$1.22M 1.17% 24
2023
Q2
$2.73M Buy
+32,489
New +$2.92M 0.87% 45

Other funds holding LNTH

Formula Growth's LNTH Position: Q2 2026 in Review

Formula Growth increased its Lantheus (LNTH) stake by 57% in Q2 2026, buying an estimated $851K and bringing the position to 25,131 shares worth $2.79M. The position accounts for 0.98% of the portfolio, ranked #35.

Formula Growth first reported a position in LNTH in Q2 2023 and has held it in 6 quarters since. The position peaked at $3.42M in Q3 2023. 466 funds tracked by Wall St. Rank hold LNTH as of Q2 2026.

  • Formula Growth held 25,131 shares of Lantheus worth $2.79M as of Q2 2026.
  • Formula Growth bought 9,131 Lantheus shares in Q2 2026, an estimated $851K.
  • Lantheus made up 0.98% of Formula Growth's portfolio in Q2 2026, its #35 holding.
  • Formula Growth first reported a position in Lantheus in Q2 2023 and has held it in 6 quarters since.
  • Formula Growth's Lantheus position peaked at $3.42M in Q3 2023.
  • 466 funds tracked by Wall St. Rank held Lantheus as of Q2 2026.

Based on Formula Growth's 13F filing for Q2 2026, filed 17 Aug 2026.